Overview

A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This Phase 1 study aims to determine the oral bioavailability of a single dose of a new vapendavir tablet formulation and compare it to that of the previous vapendavir capsule formulation. The safety of both drug products will also be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
Biota Pharmaceuticals, Inc.